Super CC Color-Correction Care All Over Blur CC Cream
- Manufacturer
- Markwins Cosmetic (ShenZhen) Co., Ltd.
- Effective date
- 2018-12-28
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 00:35:02
Label at a glance#
ProductSuper CC Color-Correction Care All Over Blur CC Cream
Active ingredientTITANIUM DIOXIDE, ZINC OXIDE
Label structure1 sections
Label contents#
Full prescribing information#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70280-100-02 | 2021-02-01 | C162847 | 48780-1 | ba0f9c33-4293-a910-e053-dadaa90a0b85 | 7e1cebf0-a92e-ebce-e053-2991aa0a4c9e |
| 70280-100-02 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-4293-a910-e053-dadaa90a0b85 | 7e1cebf0-a92e-ebce-e053-2991aa0a4c9e |
Products#
Every source-derived product name is available through these pages.
- Super CC Color-Correction Care All Over Blur CC Cream
- Titanium Dioxide, Zinc Oxide
- POLYGLYCERYL-4 ISOSTEARATE
- CALCIUM ALUMINUM BOROSILICATE
- STEARIC ACID
- TEPRENONE
- MICA
- CAPRYLYL GLYCOL
- ETHYLHEXYLGLYCERIN
- HEXYLENE GLYCOL
- PHENOXYETHANOL
- HYDROGENATED POLYDECENE (550 MW)
- BUTYLENE GLYCOL
- SODIUM CITRATE
- HYDROXYCAPRYLIC ACID
- DIMETHICONE 200
- HYDROXYCAPRIC ACID
- ISODECYL NEOPENTANOATE
- HEXYL LAURATE
- PEG-10 DIMETHICONE (600 CST)
- DIPROPYLENE GLYCOL
- TITANIUM DIOXIDE
- ZINC OXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 70280-100 | 70280-100-01, 70280-100-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| cd16e910-908e-309f-e053-2a95a90a0a25 | 7e1cebf0-a92e-ebce-e053-2991aa0a4c9e | 2021-09-28 | 7e1cebf0-a92e-ebce-e053-2991aa0a4c9e |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
